UE LifeSciences Overview
- Year Founded
-
2009
- Status
-
Private
- Employees
-
63
- Latest Deal Type
-
2ndary - Private
- Investors
-
9
UE LifeSciences General Information
Description
Developer of a healthcare technology research platform designed to offer non-invasive breast cancer detection devices. The company's platform offers a portable screening device that helps in the early-stage detection of breast cancer, enabling patients to get early treatments and a cure for cancer.
Contact Information
Website
www.uelifesciences.comCorporate Office
- 3401 Market Street
- Suite 200
- Philadelphia, PA 19104
- United States
Corporate Office
- 3401 Market Street
- Suite 200
- Philadelphia, PA 19104
- United States
UE LifeSciences Timeline
UE LifeSciences Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
8. Secondary Transaction - Private | 01-Nov-2022 | Completed | Generating Revenue | |||
7. Later Stage VC | 23-Nov-2021 | Completed | Generating Revenue | |||
6. Grant | 18-May-2018 | Completed | Generating Revenue | |||
5. Later Stage VC | 04-Oct-2016 | Completed | Generating Revenue | |||
4. Later Stage VC (Series A) | 14-Sep-2015 | Completed | Generating Revenue | |||
3. Accelerator/Incubator | 01-Jan-2014 | Completed | Generating Revenue | |||
2. Grant | 21-Aug-2012 | $878K | $150K | Completed | Generating Revenue | |
1. Angel (individual) | 01-Jan-2009 | $150K | $150K | Completed | Startup |
UE LifeSciences Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series AA-2 | ||||||||
Series AA-1 | ||||||||
Series A2 | 769 | $0.000010 | $585.18 | $585.18 | 1x | $585.18 | 4.67% | |
Series A1 | 3,077 | $0.000010 | $812.48 | $812.48 | 1x | $812.48 | 18.69% |
UE LifeSciences Comparisons
Industry
Financing
Details
UE LifeSciences Competitors (3)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Micrima | Venture Capital-Backed | Bristol, United Kingdom | ||||
Orbital Therapy | Corporation | Bedford, MA | ||||
IceCure Medical | Corporate Backed or Acquired | Caesarea, Israel |
UE LifeSciences Patents
UE LifeSciences Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
AU-2020314838-A1 | System and method for measuring tissue parameters by use of capacitive tactile sensor | Pending | 17-Jul-2019 | ||
CA-3147421-A1 | System and method for measuring tissue parameters by use of capacitive tactile sensor | Pending | 17-Jul-2019 | ||
EP-3999167-A1 | System and method for measuring tissue parameters by use of capacitive tactile sensor | Pending | 17-Jul-2019 | ||
US-20220287567-A1 | System and method for measuring tissue parameters by use of capacitive tactile sensor | Pending | 17-Jul-2019 | ||
EP-3999167-A4 | System and method for measuring tissue parameters by use of capacitive tactile sensor | Pending | 17-Jul-2019 | A61B5/0053 |
UE LifeSciences Executive Team (4)
Name | Title | Board Seat |
---|---|---|
Madhukumar MK | Chief Business Officer & Chief Executive Officer of ASEAN | |
Mihir Shah | Co-Founder, Chief Executive Officer, Board Member & President | |
Bhaumik Sanghvi | Co-Founder and Chief Operating Officer | |
Matthew Campisi | Co-Founder and Chief Technology Officer |
UE LifeSciences Board Members (3)
Name | Representing | Role | Since |
---|---|---|---|
Ari Brooks MD | Self | Board Member | |
Mihir Shah | UE LifeSciences | Co-Founder, Chief Executive Officer, Board Member & President |
UE LifeSciences Signals
UE LifeSciences Investors (9)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Bayer Foundation | Impact Investing | Minority | ||
Pfizer Foundation | Limited Partner | |||
Artha Impact | Impact Investing | Minority | ||
Carica Investments | Other | Minority | ||
Kiran Mazumdar-Shaw | Angel (individual) | Minority |
UE LifeSciences FAQs
-
When was UE LifeSciences founded?
UE LifeSciences was founded in 2009.
-
Who is the founder of UE LifeSciences?
Mihir Shah, Bhaumik Sanghvi, and Matthew Campisi are the founders of UE LifeSciences.
-
Who is the CEO of UE LifeSciences?
Madhukumar MK and Mihir Shah are the CEOs of UE LifeSciences.
-
Where is UE LifeSciences headquartered?
UE LifeSciences is headquartered in Philadelphia, PA.
-
What is the size of UE LifeSciences?
UE LifeSciences has 63 total employees.
-
What industry is UE LifeSciences in?
UE LifeSciences’s primary industry is Diagnostic Equipment.
-
Is UE LifeSciences a private or public company?
UE LifeSciences is a Private company.
-
What is UE LifeSciences’s current revenue?
The current revenue for UE LifeSciences is
. -
How much funding has UE LifeSciences raised over time?
UE LifeSciences has raised $5.28M.
-
Who are UE LifeSciences’s investors?
Bayer Foundation, Pfizer Foundation, Artha Impact, Carica Investments, and Kiran Mazumdar-Shaw are 5 of 9 investors who have invested in UE LifeSciences.
-
Who are UE LifeSciences’s competitors?
Micrima, Orbital Therapy, and IceCure Medical are competitors of UE LifeSciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »